JL Morison JL Morison

Husein Esufally

Non-Executive Chairman

Mr. Husein Esufally started his career with the Group’s FMCG (Fast Moving Consumer Goods) business, where he steered the Company for a period of 19 years, during which, the business established a strong consumer franchise. Thereafter, he served for 13 years as the Chief Executive Officer of the Hemas Group until he relinquished his position in March 2014. Presently, he serves as the Non-Executive Chairman of Hemas Holdings PLC, whilst also chairing the Boards of its FMCG and pharmaceutical manufacturing subsidiaries.

Mr. Esufally was appointed as the Non-Executive Chairman of Atlas Axillia Company (Pvt) Ltd on 19th January 2018. He also serves on the Boards of several other companies and is involved in several social projects. Mr. Esufally holds a Bachelor of Science (Honours) Degree in Electronics from the University of Sussex, UK having received his primary education at St. Thomas College, Mt Lavinia.
JL Morison JL Morison

Murtaza Esufally

Executive Managing Director

Mr. Murtaza Esufally counts more than 27 years of experience in senior management levels. He is the Chairman of Hemas Hospitals (Pvt) Ltd and Hemas Pharmaceuticals (Pvt) Ltd, and is the Non-Executive Chairman of the Centre for Poverty Analysis. He was also appointed as the Managing Director of Morison PLC, a pharma manufacturing company of the Group.

He holds a Master’s Degree in Business Administration from the Melbourne Business School of the University of Melbourne. He is a Barrister of the Lincoln’s Inn and holds a Bachelor of Law Degree from the University of Essex, UK. Mr. Esufally is an Attorney-at-Law of the Supreme Court of Sri Lanka.
JL Morison JL Morison

Steven Enderby

Non-Independent Non-Executive Director

Mr. Steven Enderby joined Hemas in March 2013 to head the Group’s efforts in Mergers and Acquisitions. He took up the position of Deputy CEO and Director of Hemas Holdings PLC in November 2013 and was subsequently Chief Executive Officer of the Company on April 2014. Mr. Enderby has had a successful track record in private equity with Actis, a leading global emerging markets fund, until his retirement in 2011 as an Actis Partner. He has led many of the most successful private equity transactions in Sri Lanka including South Asia Gateway Terminal, Ceylon Oxygen and Millennium Information Technologies. Mr. Enderby is also Non-Executive Chairman of Ironwood Capital Partners Sri Lanka’s leading private equity fund. He has served on the Boards of many leading companies in Sri Lanka and India. He is a Fellow of the Chartered Institute of Management Accountants, holds a Degree in Economics and Accounting from Queens University Belfast, and a Master’s Degree in Development Studies from the University of Melbourne
JL Morison JL Morison

Arundathi Rajakarier

Independent Non-Executive Director

Ms. Rajakarier has over 25 years working experience as a finance professional and is a founder Director of SheConsults (Pvt) Ltd., a financial consulting company. She serves on the Boards of J.L.Morrison Son & Jones PLC and John Keells PLC as an Independent Director from July 2016 and previously served on the Board of NDB Capital Holdings as an Independent Non- Executive Director, the Chairperson of the Audit, Risk and Compliance Committee and the Remuneration Committee and a member of the Investment Committee. An Associate member of the Institute of Chartered Accountants, Sri Lanka, she served as the Country Manager for ACCA Sri Lanka with additional responsibility for the Maldives and in several senior roles at NDB Bank. Prior to this she served as Finance Director of Lanka Cellular Services (Pvt) Ltd. She was trained at Ernst & Young where she served as Senior Manager in both auditing, consultancy and training.

JL Morison JL Morison

Ranjan Chakravarti

Independent Non-Executive Director

Mr. Ranjan Chakravarti is a Management Consultant & Certified Executive & Life Coach. He is a Science graduate with post-graduation in Business Management.Mr. Chakravarti has over 40 years’ experience in the global pharmaceutical industry, of which 17 years have been with innovator companies like Boehringer-Knoll, Reckitt & Colman, and Eskayef Ltd. and 23 years with leading Indian multinational companies like Lupin Laboratories and Ranbaxy.

The last 26 years he has been in senior leadership roles in India and other geographies like Asia, Middle East, Africa and Latin America, Russia, CIS & EEU. The most recent position prior to retirement in 2015 was as Head Global Pharmaceutical Business (excluding US), in Ranbaxy.Mr. Chakravarti has worked as a lead member of the Integration Team post merger oftwo of the largest pharmaceutical companies from India- Sun Pharmaceuticals & Ranbaxy Laboratories. A veteran of Pharmaceutical Industry worked extensively in multicultural environments in Functional and General Management positions across geographies. As a Marketing & Sales professional Mr. Chakravarti has launched & built strong brands in ethical/OTC and successfully led large teams in India & overseas.

He has handled many responsibilities in areas as varied as Marketing and Sales; Restructuring and Revitalizing Businesses, Setting up and managing large operations in overseas markets, Head Global Strategy & Business Development; Head Formulation Sourcing and Alliance Management; Acquisition and Divestment projects; and Organization Restructuring & Business Processes.Mr. Chakravarti has developed many leaders over the years who are currently occupying senior leadership roles in large & successful organizations. Mr. Chakravarti has served on the Board of 15 Subsidiaries of Ranbaxy spread across Western Europe, Africa, Canada, Brazil, Russia, Ukraine & Romania either as a Director or Chairman of the Board. Currently, working as a Management Consultant and Executive & Life Coach specializing in helping organizations in transition & successful high potential professionals in achieving their life goals.
JL Morison JL Morison

Kasturi Chellaraja Wilson

Managing Director-Pharmaceuticals

Kasturi is the Managing Director of Hemas Pharmaceuticals and the Group’s Logistics and Maritime sectors. She is a Fellow of the Chartered Institute of Management Accountants, UK and an Alumni of Havard Business School .Kasturi is a Memebr of the Board of Management of Hemas Holding PLC. She has also served as Board Member of CIMA, Sri Lanka. She counts for over 30 years of managerial experience in multiple industries and functions spanning from auditing, consulting, logistics, leisure and travel and pharmaceuticals. Kasturi joined Hemas in 2002 as the Finance Director of Hemtours (Presently, Diethelm Travel) and in 2005 she was appointed the Head of Shared Services for the Group and subsequently as the Chief Process Officer of the Group in 2007. In 2011 she was appointed as the Managing Director of the Transportation Sector and in 2016, Managing Director of the Pharmaceutical Distribution Business. In 2018 she was appointed a Non-Independent Non-Executive Director of Morison PLC and .Non-Executive of Capital Alliance Ltd. Kasturi

Kasturi is also a member of the Economic Policy Committee of the Ceylon Chamber of Commerce and Senior Vice president of the Sri Lanka Chamber of pharmaceutical Industry. Kasturi is also a Board member of the American Chamber of commerce.
JL Morison JL Morison

Zalmi Fazeel

Executive Vice President

Mr. Zalmi Fazeel has served as an Executive Vice President heading the finance, legal and IT operations of Saudi Cable Company, Saudi Arabia between 2013 and 2017. He served at the Savola Group, Saudi Arabia, between 2000 and 2013 in various roles, including that of Executive Director-Group Treasury, Chief Financial Officer of Edible Oil Subsidiaries, Head of Finance and IT at the United Sugar Company, and Head of Finance Shared Services. He started his career at Pfizer Sri Lanka currently known as Astron Limited, in 1984. He was appointed to the Board of Astron in 1992, which position he held until he moved to Saudi Arabia in January 2000. He was an independent Board member and Chaired the Audit committee of Hemas Hospitals (Pvt) Limited, from March 2017 to July 2018. He is a Fellow of the Chartered Institute of Management Accountants (UK). Mr. Zalmi Fazeel has been appointed as the Group Chief Financial Officer of Hemas Holdings PLC starting from 1st September 2018.